Resources

How integrated care systems can improve diabetic macular oedema care

Outputs of World Cafe Event

PA_Background

In December 2022, Bayer convened stakeholders from the eye care community to discuss practical steps to improve diabetic macular oedema (DMO) services. The aim was to gather insights and align on potential solutions that could be replicated across the NHS.

Practical Steps to improve DMO services:

Outputs of World Cafe Event

Bayer is committed to supporting healthcare institutions nationwide, recognising their uniqueness. By collaborating with centres and stakeholders across the UK, we can enhance understanding, identify areas for improvement, and assist in creating bespoke action plans based on your service model and available resources.

Building Capacity, Efficiency and Resilience
Newcastle Diagnostic Hub | Working with the NHS to drive efficiencies and service improvement
Transforming Delivery of Eyecare Services
Service Improvement
Optimising Patient Journeys & Health Systems
To improve pathway management and optimise patient journeys by improving efficiency.
PP-MACS-GB-0318, November 2024

Prescribing information for EYLEA® (aflibercept) can be found here

PP-MACS-GB-0312 | October 2024